Clinical Trials Logo

Overweight and Obesity clinical trials

View clinical trials related to Overweight and Obesity.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06323070 Recruiting - Clinical trials for Overweight and Obesity

Effects of Watermelon or Low-fat Cookie Consumption on Wellness

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

The objective of the proposed research is to determine the effects of fresh watermelon consumption on physiological indicators of wellness regarding sexual, skin and gut health in adults.

NCT ID: NCT06280625 Recruiting - Clinical trials for Overweight and Obesity

The Effect of the Inclusion of Soybean Flour on Glycemic Responses

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

Foods that release glucose rapidly, leading to spikes in blood sugar and insulin (known as high glycemic index foods), generate lower satiety responses than foods with low glycemic index. High glycemic index foods are also linked to an increased risk of developing diabetes. The partial replacement of carbohydrates in rich staple foods with soy flour has the potential to reduce glycemic response and improve satiety. In many regions of Latin America, as well as in the Middle East and North Africa (MENA) regions, bread is the staple source of calories, but it is a relatively poor source of balanced nutrition. Bread enriched with soy flour could provide higher dietary protein while moderating blood glucose (and insulin) spikes, which can help reduce insulin resistance and metabolic diseases. The results of this study could provide government and private human nutritionists with the evidence they need to formulate soy flour into bread, corn tortillas, and arepas for schools and homes.

NCT ID: NCT06269159 Recruiting - Clinical trials for Overweight and Obesity

The Power of 24-hour: Co-designing Intervention Components

Start date: September 5, 2023
Phase:
Study type: Observational

Most of the existing lifestyle interventions in adults with overweight or obesity focus on one movement behavior in isolation (i.e. moderate to vigorous physical activity (MVPA)). However, recent research suggests to incorporate all movement behaviors performed in one day to explore the possible synergistic health effects of targeting more than one behavior. Moreover, more optimal 24-hour movement behavior compositions are related with better cardiometabolic health. Literature shows that adults with obesity have less optimal 24-hour compositions (8-9). Therefore it would be of interest to discover the needs related to an optimal 24-hour movement behavior intervention for a group of adults with overweight and obesity using co-design to develop an intervention. This study will conduct a concept mapping protocol to explore the needs to of people with overweight and obesity to change their sedentary behavior into more physical activity as well to include the opinion of health care providers (HCP are physiotherapists) on the needs of their patients.

NCT ID: NCT06268262 Recruiting - Clinical trials for Overweight and Obesity

Surgical-imaging Research on Obesity (SIRO)

Start date: March 1, 2023
Phase:
Study type: Observational

The global obesity epidemic is well established, and is an important public health issue. The previous researches had applied the clues that obesity is a kind of systemic disease. The investigators hypothesized that a serious alteration of the body systems will occur after bariatric surgery, which may shed light on the mechanisms of obesity. Thus, the research aims to combine the imaging and surgery to investigate the alterations of the body that induced by obese and alterations after surgery.

NCT ID: NCT06256653 Recruiting - Obesity Clinical Trials

Assess the Effect of a Whole Fruit Powder on Gut Microbiome Function on Overweight & Obese Adults

Start date: January 29, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the effect of freeze-dried blueberry powder on the gut microbiome in overweight and obese adults. The main question[s] it aims to answer are: - Does the supplementation of freeze-dried blueberry powder reduce the risk of obesity or lower the weight of people with a high BMI? - Does freeze-dried blueberry powder alter the gut microbiome function? Participants will; - Mix one sachet of Study Product (freeze-dried blueberry powder/placebo) into breakfast/dessert/yoghurt daily for 56 days during the intervention phase. - Partake in 4 site visits over the 14-week period, including an initial screening visit and a follow-up visit after the intervention phase. Researchers will compare the effect of freeze-dried blueberry powder with a placebo in a population comprising overweight and obese adults to see if the gut microbiome is altered and if there is a change in body composition.

NCT ID: NCT06253728 Recruiting - Clinical trials for Overweight and Obesity

A Study of Biochemical Response to Alternative Proteins

COBRA
Start date: January 18, 2024
Phase: N/A
Study type: Interventional

The overall objective of this research is to determine the digestive faith and health impact of protein and fiber rich foods in different food matrices in type 2 diabetes risk population. This is achieved by controlled postprandial intervention where plasma amino acids, lipids, glucose metabolism, bile acids and microbial metabolites are evaluated as well as fecal microbiota and metabolites.

NCT ID: NCT06245369 Recruiting - Clinical trials for Overweight and Obesity

SWITCH Diets Study: Self-monitoring With Internet Technology to Choose Healthy Diets

SWITCH
Start date: April 1, 2024
Phase: N/A
Study type: Interventional

The goal of the Self-monitoring With Internet Technology to Choose Healthy Diets (SWITCH) study is to examine a 12-week remotely delivered program designed to help adults adopt a healthy dietary lifestyle and lose weight in a diverse cohort of adults with overweight/obesity. The intervention uses a self-determination theory framework to provide a deeper understanding of the factors that influence dietary behavior within the context of tracking. This study incorporates autonomy-supportive strategies to encourage participants to feel more in control of their dietary choices and will provide information and resources to boost participant's competence in achieving their dietary goals. The intervention includes weekly learning modules to support healthy eating and weight loss and daily dietary tracking with visual feedback, all accessible within the SWITCH app.

NCT ID: NCT06244888 Recruiting - Clinical trials for Overweight and Obesity

Control Systems Engineering for Weight Loss Maintenance

Start date: February 12, 2024
Phase: Phase 2
Study type: Interventional

This project capitalizes on principles of control systems engineering to build a dynamical model that predicts weight change during weight loss maintenance using behavioral, psychosocial, and environmental indicators evaluated in a system identification experiment. A 6-month behavioral obesity treatment will be administered to produce weight loss. Participants losing at least 3% of initial body weight will be followed for an additional 12 months via daily smartphone surveys that incorporates passive sensing to objectively monitor key behaviors. Survey data pertaining to behavioral, psychosocial, and environmental indicators will be used to develop a controller algorithm that can predict when an individual is entering a heightened period of risk for regain and why risk is elevated. Interventions targeting key risk indicators will be randomly administered during the system ID experiment. Survey and passive sensing data documenting the effects of the interventions will likewise drive development of the controller algorithm, allowing it to determine which interventions are most likely to counter risk of regain.

NCT ID: NCT06242847 Recruiting - Psoriasis Clinical Trials

Role of Insulin Action in Psoriasis Pathogenesis

Start date: February 2, 2024
Phase:
Study type: Observational

The goal of this study is to collect more information from people with plaque psoriasis and to determine if insulin plays a role in the pathogenesis of psoriasis. The main question it aims to answer is if insulin action is preserved or even enhanced in psoriatic lesions despite insulin resistance elsewhere. Participants with plaque psoriasis will have punch biopsies taken of lesional and non-lesional skin after an overnight fast and then during an oral glucose tolerance test. Biopsy specimens will then be assessed for markers of insulin action.

NCT ID: NCT06230523 Recruiting - Obesity Clinical Trials

A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight

Start date: February 5, 2024
Phase: Phase 2
Study type: Interventional

The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to investigate weight management efficacy and safety with LY3841136 compared with placebo in adult participants with obesity or overweight. The study will last about 64 weeks and may include up to 13 visits.